{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:04:46Z","timestamp":1773281086960,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ophtha.2011.07.034","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T20:05:06Z","timestamp":1322078706000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["A Randomized, Dose-Escalation Study of Subconjunctival and Intravitreal Injections of Sirolimus in Patients with Diabetic Macular Edema"],"prefix":"10.1016","volume":"119","clinical-trial-number":[{"clinical-trial-number":"nct00401115","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Pravin U.","family":"Dugel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Blumenkranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne A.","family":"Solley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Naor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2011.07.034_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archopht.122.4.552","article-title":"The prevalence of diabetic retinopathy among adults in the United States","volume":"122","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.034_bib4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0161-6420(84)34102-1","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy","volume":"91","author":"Klein","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.07.034_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ophtha.2008.10.016","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy","volume":"116","author":"Klein","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.07.034_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ophtha.2008.06.015","article-title":"A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.07.034_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004397-200404440-00006","article-title":"Diabetic macular edema: a review of past, present, and future therapies","volume":"44","author":"Thompson","year":"2004","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2011.07.034_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/14728214.12.4.591","article-title":"Emerging pharmacotherapies for diabetic macular edema","volume":"12","author":"Furlani","year":"2007","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.ophtha.2011.07.034_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00007691-200110000-00012","article-title":"From beach to bedside: history of the development of sirolimus","volume":"23","author":"Napoli","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ophtha.2011.07.034_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63311-1","article-title":"Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy","volume":"165","author":"Poulaki","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ophtha.2011.07.034_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI0213776","article-title":"Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF","volume":"109","author":"Poulaki","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ophtha.2011.07.034_bib12","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ophtha.2011.07.034_bib13","first-page":"299","article-title":"mTOR as a positive regulator of tumor cell responses to hypoxia","volume":"279","author":"Abraham","year":"2004","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ophtha.2011.07.034_bib14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm1052","article-title":"mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways","volume":"10","author":"Majumder","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2011.07.034_bib15","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","article-title":"Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin","volume":"22","author":"Hudson","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ophtha.2011.07.034_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ophtha.2011.07.034_bib17","doi-asserted-by":"crossref","first-page":"6382S","DOI":"10.1158\/1078-0432.CCR-050008","article-title":"Mammalian target of rapamycin inhibition","volume":"10","author":"Dutcher","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ophtha.2011.07.034_bib18","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1167\/iovs.05-0096","article-title":"Effect of ruboxistaurin on blood-retinal barrier permeability in relation to severity of leakage in diabetic macular edema","volume":"46","author":"Strom","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.07.034_bib19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1167\/iovs.03-0955","article-title":"Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412","volume":"45","author":"Campochiaro","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.07.034_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1167\/iovs.05-0757","article-title":"Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients","volume":"47","author":"Aiello","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.07.034_bib21","doi-asserted-by":"crossref","first-page":"28644","DOI":"10.1074\/jbc.M301479200","article-title":"Intestinal sugar absorption is regulated by phosphorylation and turnover of protein kinase C betaII mediated by phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent pathways","volume":"278","author":"Helliwell","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ophtha.2011.07.034_bib22","doi-asserted-by":"crossref","first-page":"32468","DOI":"10.1074\/jbc.271.50.32468","article-title":"Rapamycin inhibits protein kinase C activity and stimulates Na+ transport in A6 cells","volume":"271","author":"Rokaw","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ophtha.2011.07.034_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bjo.86.4.363","article-title":"Is diabetic retinopathy an inflammatory disease?","volume":"86","author":"Adamis","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.034_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/PL00000199","article-title":"Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 formulation","volume":"49","author":"Attur","year":"2000","journal-title":"Inflamm Res"},{"key":"10.1016\/j.ophtha.2011.07.034_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.04-2431fje","article-title":"Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty","volume":"19","author":"Nuhrenberg","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.ophtha.2011.07.034_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yexcr.2004.07.002","article-title":"Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro","volume":"300","author":"Butzal","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ophtha.2011.07.034_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2003.09.003","article-title":"Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1-independent pathway","volume":"172","author":"Castro","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ophtha.2011.07.034_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1096\/fj.01-0658com","article-title":"Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling","volume":"16","author":"Humar","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.ophtha.2011.07.034_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2011.07.034_bib30","series-title":"Rapamune","year":"2009"},{"key":"10.1016\/j.ophtha.2011.07.034_bib31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.2004.048199","article-title":"The efficacy of sirolimus in the treatment of patients with refractory uveitis","volume":"89","author":"Shanmuganathan","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.034_bib32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"issue":"suppl","key":"10.1016\/j.ophtha.2011.07.034_bib33","doi-asserted-by":"crossref","first-page":"B101","DOI":"10.1016\/S0149-2918(00)89027-X","article-title":"Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus","volume":"22","author":"MacDonald","year":"2000","journal-title":"Clin Ther"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011006889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011006889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:01:07Z","timestamp":1758981667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642011006889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0161642011006889"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.034","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized, Dose-Escalation Study of Subconjunctival and Intravitreal Injections of Sirolimus in Patients with Diabetic Macular Edema","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}